| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 10/09/2003 | WO2002070744A3 Adenoviral library assay for e2f regulatory genes and methods and compositions for screening compounds |
| 10/09/2003 | WO2002070701A3 Novel human gnrh receptor |
| 10/09/2003 | WO2002069947A3 Antisense oligonucleotides and trichostatin analogue histone deacetylase-4 inhibitors against cancer |
| 10/09/2003 | WO2002066629A3 Recombinant vector containing infectious human cytomegalovirus genome with preserved wild-type characteristics of clinical isolates |
| 10/09/2003 | WO2002060955A3 Modified antibodies and methods of use |
| 10/09/2003 | WO2002060318A3 Detection of methylated cpg rich sequences diagnostic for malignant cells |
| 10/09/2003 | WO2002059381A3 Gene for identifying individuals with familial dysautonomia |
| 10/09/2003 | WO2002059315A3 Human nucleic acids and polypeptides and methods of use thereof |
| 10/09/2003 | WO2002059154A3 Neutralizing human monoclonal antibodies against hiv-1, their production and uses |
| 10/09/2003 | WO2002057491A3 Direct multiplex characterization of genomic dna |
| 10/09/2003 | WO2002057484A3 Method and test system for identifying substances which protect nerve cells |
| 10/09/2003 | WO2002057429A3 A method for producing a population of homozygous stem cells having a pre-selected immunophenotype and/or genotype |
| 10/09/2003 | WO2002056905A3 Molecular antigen array |
| 10/09/2003 | WO2002053743A3 Mammalian tribbles signaling pathways and methods and reagents related thereto |
| 10/09/2003 | WO2002046218A3 Treatment of disease by inducing cell apoptosis |
| 10/09/2003 | WO2002040676A3 Mutant allergens |
| 10/09/2003 | WO2002034284A3 Methods of therapy for hiv infection |
| 10/09/2003 | WO2002033099A3 Human kinases |
| 10/09/2003 | WO2002031160A3 Regulation of human phospholipase a2-like enzyme |
| 10/09/2003 | WO2002029072A3 Targetting molecules for adenoviral vectors |
| 10/09/2003 | WO2002024940A3 Means for the identification of compounds capable of inhibiting karap-transduced signals |
| 10/09/2003 | WO2002022664A3 Antigenic proteins of shrimp white spot syndrome virus and uses thereof |
| 10/09/2003 | WO2002021418A3 Method and system for identifying commercially distributed organisms |
| 10/09/2003 | WO2002020563A3 RECEPTOR IN THE EDb FIBRONECTIN DOMAIN |
| 10/09/2003 | WO2002017953A3 Thrombomodulin analogs for use in recovery of signal cord injury |
| 10/09/2003 | WO2002016612A3 Genes and proteins, and their uses |
| 10/09/2003 | WO2002012290A3 Sid polypeptides binding to pathogenic strain of the hepatitis c virus |
| 10/09/2003 | WO2002010382A3 Trp8, trp9 and trp10, markers for cancer |
| 10/09/2003 | WO2002006313A3 Regulation of human glutamate receptor delta-1 subunit |
| 10/09/2003 | WO2001071027A3 mRNA AMPLIFICATION |
| 10/09/2003 | US20030192078 Modifying a wild-type structural gene sequence encoding an insecticidal protein of Bacillus thuringiensis to enhance the expression of protein in plants by removing polyadenylation signals and retaining a sequence which codes such protein |
| 10/09/2003 | US20030192077 Production of silk-like proteins in plants |
| 10/09/2003 | US20030192076 Obtaining a population of plants transformed to express a polypeptide having a specific amino acid sequence, growing such plants under the growth limiting condition to detect such plants having enhanced growth and/or fruit yield |
| 10/09/2003 | US20030192075 Elicitor from cladosporium |
| 10/09/2003 | US20030192074 Encoding an MLA polypeptide which is capable of recognising and activating a race specific defense response in a plant into which the nucleic acid is introduced and expressed, in response to challange with a congnate Erysiphe graminis |
| 10/09/2003 | US20030192073 Plant biotin synthase |
| 10/09/2003 | US20030192072 Isolation of a glyphosate herbicide resistant EPSP synthase ( 5-enolpyruvylshikimate-3-phosphte synthase) coding sequence and its regulatory elements from Eleusine indica |
| 10/09/2003 | US20030192071 Isolated and purified nucleic acids comprising a gene and a regulatory region for the gene expression of the same |
| 10/09/2003 | US20030192069 Glycerol kinase gene disruptions, compositions and methods related thereto |
| 10/09/2003 | US20030192068 Production of recombinant polypeptides by bovine species and transgenic methods |
| 10/09/2003 | US20030192067 Delivery system |
| 10/09/2003 | US20030192066 DNA molecule containing an adenoviral inverted terminal repeat (ITR), a packaging signal, a transcriptional control region, effector or reporter gene, generating an infectious, replication-defective genetic engineered adenoviral vector |
| 10/09/2003 | US20030192064 Transcription enhancers such as serine protease inhibitor-growth hormone responsive element |
| 10/09/2003 | US20030191302 Membrane's binding properties with respect to nucleic acids being adjustable by controlling the conditions in an ambient medium, characterized in that membrane is functionalized with deportonable groups |
| 10/09/2003 | US20030191301 Nucleic acid molecule encoding a gene product which, when knocked out, or prevented from expression results in a high growth phenotype |
| 10/09/2003 | US20030191300 Antisense modulation of bcl-x expression |
| 10/09/2003 | US20030191297 Avian ghd genes and their use in methods for sex identification in birds |
| 10/09/2003 | US20030191285 Novel g protein-coupled receptor proteins and dnas thereof |
| 10/09/2003 | US20030191280 Class ii cytokine receptor-7 |
| 10/09/2003 | US20030191277 Comprising a connecting peptide with aromatic amino acid residue and a cleavage site; transforming a yeast cell with expression vector; increased folding stability |
| 10/09/2003 | US20030191114 Binding to ligand; induce signals |
| 10/09/2003 | US20030191084 High affinity nucleic acid ligands of complement system proteins |
| 10/09/2003 | US20030191080 Cardiovascular disorders; hypotensive agents |
| 10/09/2003 | US20030191079 Methods for treating and preventing infectious disease |
| 10/09/2003 | US20030191078 Prevent reproduction of oligonucleotides |
| 10/09/2003 | US20030191077 Method and reagent for the treatment of asthma and allergic conditions |
| 10/09/2003 | US20030191076 Induction of immunology response; transgenic plant; measles |
| 10/09/2003 | US20030191075 Modulation of gene expression of nucleic acids; sterol binding to oligonucleotides |
| 10/09/2003 | US20030191074 Antibody therapy; immobilization |
| 10/09/2003 | US20030191072 Gene therapy for proliferative vitreoretinopathy |
| 10/09/2003 | US20030191067 Hepatitis C inhibitor tri-peptides |
| 10/09/2003 | US20030191065 Insulin-like growth factor; genetic engineering; central nervous system disorders |
| 10/09/2003 | US20030191062 Bone marrow specific protein |
| 10/09/2003 | US20030191060 Respiratory system disorders; cardiovascular disorders; controlling signal transduction |
| 10/09/2003 | US20030191056 Immobilization onto polyoxyethylene glycol |
| 10/09/2003 | US20030191052 Infection therapy; binding of mannan lecithin to protein |
| 10/09/2003 | US20030191048 Gene expression profile for KSHV infection and methods for treating same |
| 10/09/2003 | US20030191039 Modified subtilisins and detergent, compositions containing same |
| 10/09/2003 | US20030190754 Using the promintron sequence from Agrobacterium; recombinant DNA |
| 10/09/2003 | US20030190753 Vectors for gene transfer |
| 10/09/2003 | US20030190752 Escherichia coli csrB gene, RNA encoded thereby, and methods of use thereof |
| 10/09/2003 | US20030190751 Directed switch-mediated DNA recombination |
| 10/09/2003 | US20030190749 Expression element that comprises a gene linked to sequences that are inducible and/or repressible; mutations; useful in diagnositics, therapeutics and drug discovery |
| 10/09/2003 | US20030190746 Gene expression control system and its use in recombinant virus packaging cell lines |
| 10/09/2003 | US20030190744 Method and apparatus for performing biological reactions on a substrate surface |
| 10/09/2003 | US20030190740 Protease and peptidase-resistant proteins; Drug screening for control of cell division, apoptosis; for cancer treatment |
| 10/09/2003 | US20030190739 Tankyrase2 materials and methods |
| 10/09/2003 | US20030190737 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells |
| 10/09/2003 | US20030190735 Oncoprotein protein kinase |
| 10/09/2003 | US20030190734 Invention provides DNAs, vectors and host cells for the efficient production of various enzymes in the mevalonate pathway or for converting isopentyl pyrophosphate to farnesyl pyrophosphate synthase |
| 10/09/2003 | US20030190733 Desaturase genes and uses thereof |
| 10/09/2003 | US20030190731 Used as pharmaceuticals, diagnostics, biosensors and bioreactors; PRO polypeptides |
| 10/09/2003 | US20030190730 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 10/09/2003 | US20030190729 Used as pharmaceuticals, diagnostics, biosensors and bioreactors; PRO polypeptides |
| 10/09/2003 | US20030190728 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 10/09/2003 | US20030190727 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 10/09/2003 | US20030190726 Used as pharmaceuticals, diagnostics, biosensors and bioreactors; PRO polypeptides |
| 10/09/2003 | US20030190725 Used as pharmaceuticals, diagnostics, biosensors and bioreactors; PRO polypeptides |
| 10/09/2003 | US20030190724 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 10/09/2003 | US20030190723 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 10/09/2003 | US20030190722 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 10/09/2003 | US20030190721 Used as pharmaceuticals, diagnostics, biosensors and bioreactors; PRO polypeptides |
| 10/09/2003 | US20030190720 Used as pharmaceuticals, diagnostics, biosensors and bioreactors; PRO polypeptides |
| 10/09/2003 | US20030190719 Used as pharmaceuticals, diagnostics, biosensors and bioreactors; PRO polypeptides |
| 10/09/2003 | US20030190718 Used as pharmaceuticals, diagnostics, biosensors and bioreactors; PRO polypeptides |
| 10/09/2003 | US20030190717 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 10/09/2003 | US20030190715 Novel proteins and nucleic acids encoding same |
| 10/09/2003 | US20030190709 Modulation apoptosis; Alzheimer's diseases; Parkinson's disease; amyotropic lateral sclerosis |
| 10/09/2003 | US20030190708 Novel hepatoma-derived growth factor-like proteins, polynucleotides encoding them and methods of use |
| 10/09/2003 | US20030190707 17 human secreted proteins |